These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 2553629
1. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Farnsworth A, Laverty C, Stoler MH. Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629 [Abstract] [Full Text] [Related]
3. Human papillomavirus DNA in glandular dysplasia and microglandular hyperplasia: presumed precursors of adenocarcinoma of the uterine cervix. Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ. Obstet Gynecol; 1989 Jun; 73(6):1005-8. PubMed ID: 2542853 [Abstract] [Full Text] [Related]
4. Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status. Anciaux D, Lawrence WD, Gregoire L. Int J Gynecol Pathol; 1997 Apr; 16(2):103-10. PubMed ID: 9100062 [Abstract] [Full Text] [Related]
5. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs LB, Faras AJ. Cancer Res; 1988 Feb 15; 48(4):993-8. PubMed ID: 2827890 [Abstract] [Full Text] [Related]
6. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: analysis by in situ hybridization. Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K. Gynecol Oncol; 1989 Dec 15; 35(3):345-8. PubMed ID: 2557270 [Abstract] [Full Text] [Related]
11. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Leary J, Jaworski R, Houghton R. Pathology; 1991 Apr 15; 23(2):85-9. PubMed ID: 1660591 [Abstract] [Full Text] [Related]
12. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ. J Pathol; 2003 Dec 15; 201(4):535-43. PubMed ID: 14648656 [Abstract] [Full Text] [Related]
14. The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia. Colgan TJ, Lickrish GM. Gynecol Oncol; 1990 Feb 15; 36(2):246-9. PubMed ID: 2298414 [Abstract] [Full Text] [Related]
15. The differential expression of the HER-2/neu oncogene among high-risk human papillomavirus-infected glandular lesions of the uterine cervix. Roland PY, Stoler MH, Broker TR, Chow LT. Am J Obstet Gynecol; 1997 Jul 15; 177(1):133-8. PubMed ID: 9240596 [Abstract] [Full Text] [Related]
17. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C. Am J Surg Pathol; 2003 Feb 15; 27(2):187-93. PubMed ID: 12548164 [Abstract] [Full Text] [Related]
20. Continuity of human papillomavirus (HPV) type between neoplastic precursors and invasive cervical carcinoma. An in situ hybridization study. Wilbur DC, Bonfiglio TA, Stoler MH. Am J Surg Pathol; 1988 Mar 15; 12(3):182-6. PubMed ID: 2830800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]